Rose Street Pharmacy

0118 9078188 Wokingham Medical Centre, Rose Street Pharmacy, 23 Rose Street , Wokingham, Berkshire, RG40 1XS
http://www.rosestreetpharmacy.co.uk

News:

  • Community Pharmacy Patient Questionnaire
  • Rose Street Pharmacy 2018 Annual Patient Survey
  • Cannabis addiction 'rising among women and over 40s'

Overview

Rose Street Pharmacy staff

Welcome to the brand new and extremely cutting edge Rose Street Pharmacy, based in the Wokingham Medical Centre. We are Wokingham's only independent pharmacy and offer the most high-tech service available.

Our dispensing environment is unique due to the fact that we employ a state-of-the-art robot that ensures that everything we do is optimised for safety. The robot all but eliminates human error from the process leaving customers in the knowledge that they receive the best possible care.

We also stay open longer for your healthcare needs so you can pop in at a time that suits you rather than having to inconvenience yourself during business hours. You no longer have to plan your day around collecting your prescription because we are here early, late and all weekend.

Keeping track of your medicine has never been easier because we do that all for you - repeat ordering, collection, SMS reminders, delivery and the electronic prescription service; we are geared up for all of these and more.

Rose Street Pharmacy's staff are all friendly, competent and aim to provide the smoothest, most hassle free customer experience around. Feel free to visit us for a chat, to look around or to be amazed by our friendly dispensing robot.

We hope to see you in the near future.

Opening times

Monday 07:00 - 22:30
Tuesday 07:00 - 22:30
Wednesday 07:00 - 22:30
Thursday 07:00 - 22:30
Friday 07:00 - 22:30
Saturday 08:00 - 21:00
Sunday 09:00 - 18:30

Public holidays and other dates

2020
Apr 10Closed
Apr 13Closed
May 08Closed
May 25Closed

Additional information

We will be closed all day on Bank and Public Holidays.

Last verified on 20/11/2019

Departments and services

To search for a specific treatment, use our full list of departments

Latest news

Community Pharmacy Patient Questionnaire

‘Every year we undertake an annual patient survey to enable our patients to provide valuable feedback on the services that we provide. The survey, undertaken by all community pharmacies in England, is called the Community Pharmacy Patient Questionnaire. The report of our survey results allows us to identify the areas where we are performing most strongly, the areas for improvement and the actions required to address issues raised by respondents. Our results for 2017/18 (or 2018/19) are provided here.

 

Associated document

Pharmacy Patient Questionnaire (.pdf, 146 KB)

Last updated on 12 February 2019.

Rose Street Pharmacy 2018 Annual Patient Survey

Final report for Rose Street Pharmacy's 2017-18 community pharmacy patient questionnaire.

This year we increased our circulation to 300 surveys of which we received 87% (261) back. We amalgamated the results from all of them. Much akin to last year the overall ethos was positivity.

Patients were pleased that we had increased our seating capacity from four to five chairs, but in the winter that area still suffered from being close to the constantly opening automatic doors. Overall satisfaction was at a high of 94% and many extra written comments mentioned staff knowledge and, in particular, how capable our pharmacists are.

There were a couple of critical comments regarding our dispensary stock holding, but given the current market issues within pharmacy we can only assume these patients suffered from any of the various medicine shortages that occur at any given time.

Not a single person was seemingly unaware that we had a consultation room – 100% awareness of that fact is quite the coup. 

We would consider this a successful year for our survey and genuinely appreciate the time given by our patients to contribute.

Last updated on 19 June 2018.

Cannabis addiction 'rising among women and over 40s'

Cannabis addiction is rising among women

Addiction to cannabis is rising among people above the age of 40, and women in particular, according to a study by the University of York.

In the past 10 years, the number of women citing the drug as their sole concern at treatment centres more than doubled, from 471 to 1008.

Researchers blame an increase in the potency of the drug and are calling for more and better treatment.

Cannabis is still however primarily used by young men.

The study analysed figures from Public Health England on people seeking help at drug treatment centres between 2005-06 and 2015-16.

The increase comes despite fewer people using cannabis. The number of people who use it at least once a month has fallen from two million to 1.4 million during the past decade, according to the Crime Survey for England and Wales.

It remains the most popular illegal recreational drug in the UK, however.

Report author Ian Hamilton, a lecturer in addiction at York University, said: "The narrative is that cannabis is a young person's problem.

"That is still the case, but we are seeing a steady and significant rise in addiction problems amongst people over 40, particularly women.

"Cannabis is cheap and widely available. And many women consider it to be benign.

"For many people it will be, but there are a significant number who go on to develop problems.

"Older people were probably used to cannabis at a lower strength. Now, the market is awash with higher potency stuff, often grown domestically.

"In some cases, resin can be nearly three times stronger than drugs on the street in 2005.

"Higher potency cannabis, which is often combined with tobacco, could increase the likelihood of people developing health problems."

'I thought I would be able to control it'

Jayne and Emma, not their real names, are seeking treatment for cannabis addiction.

Jayne told BBC Radio 4's Woman's Hour programme: "It was cheap. And I didn't have much money.

"I also thought it wouldn't cause consequences. There's the illusion that you can do everything you need to do as a mother.

"But as I used more and more of it, I found I couldn't go out and take my children to school. I really began to neglect them."

Emma told the programme: "My husband was angry all the time and I felt I was walking on eggshells. My mum was physically abusive when I was younger, and that has always stayed with me. I guess it was easier to be out of it really."


Many people believed cannabis was not addictive, Mr Hamilton said.

"This is a myth. Yet not everyone will experience problems," he said.

"It's a bit like wine - some people can enjoy a glass, others become alcoholics.

"Yet as the strength of the product has increased, it's as if people are moving immediately to the strength-equivalent of a vodka."

Last updated on 19 June 2018.

New hope for Type 1 diabetes

BRITISH scientists have made a major breakthrough in their understanding of Type 1 diabetes. They say the rapid decline in insulin production that causes the debilitating condition continues to fall over seven years and then stabilises.

Researchers found evidence that the amount produced declines by almost 50 percent each year for seven years. 

Only at that point do insulin levels stabilise.

The finding by a team at the University of Exeter Medical School is a major step forward in understanding Type 1 and contradicts previous beliefs that the insulin produced by sufferers relentlessly with time. 

It offers hope that new strategies could be developed to preserve insulin secreting cells in patients. 

Dr Beverley Shields, who led the research, said: “This finding is really exciting. It suggests that a person with Type 1 will keep any working beta-cells they still have seven years after diagnosis. 

"We are not sure why this is; it may well be that there is a small group of resilient beta-cells resistant to immune attack and these are left after all the susceptible beta-cells are destroyed. Understanding what is special about these resilient beta-cells may open new pathways to treatment.”

Type 1 affects around 400,000 people in the UK. 

The disease commonly starts in childhood but can develop at any age and causes the body’s own immune system to attack and destroy insulin-producing cells in the pancreas, leaving the patient dependent on life-long injections.

The breakthrough study, published in Diabetes Care, measured C-peptide, which is produced at the same time and in the same quantities as the insulin that regulates blood sugar. 

By measuring C-peptide levels in blood or in urine scientists can tell how much insulin a person is producing even if they are taking insulin injections as treatment. 

Researchers studied 1,549 people with Type 1 from Exeter and Tayside, Scotland.

Professor Andrew Hattersley, a Consultant in Diabetes at the Royal Devon and Exeter Hospital and Research Professor at the University of Exeter Medical School, said: “Now we know there is a seven year switch the next question is why? 

“Has the immune attack stopped or are we left with super beta-cells that can resist the immune onslaught. 

“Any insights into halting the relentless destruction of the precious insulin-producing cells are valuable. We could not have made this progress without the help of over 1,500 patients. We owe it to them to try to find answers that might help patient care quickly.”

Karen Addington, the chief executive of the Type 1 diabetes charity JDRF, said: “These results provide further evidence the immune system’s assault on insulin-producing beta cells is not as complete as we once believed and may change over time. 

“This further opens the door to identifying ways to preserve insulin production in people diagnosed with or living with Type 1.”

The study was supported by JDRF , the Wellcome Trust and the National Institute of Health Research.

Last updated on 19 June 2018.

Community Pharmacy Annual Questionnaire

Report for 2016-17 community pharmacy patient questionnaire results.

 

We distributed approximately 220 questionnaires and analysed the first 200 returned back to us to compile our report.

 

Our findings were mostly what we expected: our patients are very satisfied overall, but they found the comfort of our seating area a bit lacking and during the winter months we suffer from the entrance to the pharmacy being very exposed to the elements.

 

Pretty much every aspect of the questionnaire elicited results whereby patients were 90% satisfied and where this was not the case it was due to a lack of awareness of services (e.g. the existence of a consultation room and people not using the pharmacy as a source of lifestyle advice). We were very pleased to discover that patients held a high opinion of our staff and our service regarding our stock levels and speed/efficiency of processing prescriptions.

 

Politeness, clinical knowledge and overall customer service were highlights, all three receiving ratings of satisfaction above 95%.

 

The big money figure of a score of 92% when patients consider the pharmacy and their experience overall is very pleasing, especially considering our large volume of dispensing.


We would like to thank everyone for giving their time in taking part in our questionnaire and look forward to improving our service and provision where necessary.

 

Last updated on 02 April 2017.

Beat stress at work

beat stress

With an average of 40 days' unpaid overtime a year, Britons work the longest hours in Europe. Long hours and a heavy workload can cause stress. In 2010/11 about 400,000 people in the UK reported work-related stress at a level they believed was making them ill.

Psychological problems, including stress, anxiety and depression, are behind one-in-five visits to a GP.

Some pressure at work can be motivating, but when it becomes excessive it can eventually lead to work-related stress.

Stress is “the adverse reaction people have to excessive pressures or other demands placed on them”, according to the Health and Safety Executive (HSE).

Stress symptoms include a pounding heart or palpitations, a dry mouth, headaches, odd aches and pains and loss of appetite for food and sex.

Work stress can be sparked by things such as a formal warning, bullying, victimisation, increased work pressure, deadlines and management changes.

The way you deal with stress can encourage unhealthy behaviour, such as smoking and drinking too much, which can increase your risk of heart disease.

Good stress management in the workplace is therefore critical to your overall health.

Life coach Suzy Greaves says one of the key skills to managing workplace stress is knowing how to say no.

"I’m constantly challenging clients who say they have no choice but to overwork," she says. "I coach people to become empowered and believe they have a choice."

She explains that saying yes can win you brownie points in the short term, but if you take on too much and fail to deliver, it can be a disastrous long-term strategy.

"Have confidence in your ‘no’ when you think it's the right decision, even though it may not be the most popular one," she says. "In the long term, your ability to say no will be one of your most valuable attributes."

Greaves says you can prevent exhaustion by knowing how much work you can take on. By taking on too much, you could end up doing nothing well.

Calculate how long you'll need to deal with your current workload so that you can see if you have any extra capacity.

“If you’re extremely busy and your boss asks you to do more, you can say no. Outline your reasons in a specific, measurable way, but always offer a solution.”

Learn to recognise the physical effects of stress and do something about it before it makes you really ill. Beware of work stress spilling over into other areas of your life.

Whatever the source of your stress, speak to your manager or someone in your organisation that you feel comfortable talking to. Or get outside help.

Employers have a duty to ensure the health, safety and welfare of their employees. This comes under the Health and Safety at Work Act 1974. They're also required to conduct risk assessments for work-related stress.

If the problem is not work-related, they may be able to support you in some way or help to take some pressure off you at work while you resolve the stress in your personal life.

The HSE supports anyone who is responsible for tackling work-related stress in an organisation.

That might be the person who has responsibility for human resources, a health and safety officer, trade union representatives or line managers.

The HSE believes good management practices can help reduce work-related stress. It offers a management standards approach to help employers take sensible and practical steps to minimise stress in the workplace.

Your GP can also help. Doctors aren't experts in employment law, but they can help you analyse the situation and refer you to more specialised help if necessary.

Last updated on 20 March 2017.

Final phase of ‘The earlier, the better’ campaign

NHS ENGLAND EARLIER BETTER

In January NHS England wrote to community pharmacies asking for their support for the national marketing campaign, ‘The earlier, the better’, which runs until the end of March 2014.

NHS England report that they have had a fantastic response to the campaign and support from community pharmacy teams has helped towards the successful launch of the campaign. The key campaign messages have been seen everywhere from national billboard and radio adverts to in-store point of sale.

As the final stage of the campaign commences, NHS England is asking community pharmacy teams to be social media champions of the campaign. To give it one final push they have developed a stock set of tweets which include a trackable link to allow NHS England to nationally evaluate the campaign:

#earlierbetter – a national health conversation 

  • Pharmacists are expert in many aspects of healthcare and can offer advice on a wide range of long-term conditions #earlierbetter
  • Your local pharmacist can provide quick health advice on minor ailments, medication and prescription concerns #earlierbetter
  • Feeling unwell? Pharmacists are expert in many aspects of healthcare & offer advice on a wide range of long-term conditions #earlierbetter
  • Feeling under weather? The earlier you get advice, the better. Find your local pharmacist: http://bddy.me/1gqk05m #earlierbetter
  • Sore throat? If you are feeling under the weather speak to your pharmacist: http://bddy.me/1c15P3Z  #earlierbetter
  • Feeling under the weather? Get online winter health advice here: http://bddy.me/1f6beZT or visit your pharmacist #earlierbetter
  • Worried about an elderly relative that is feeling under the weather? Get online health advice here: bddy.me/1f6beZT #earlierbetter

A comprehensive suite of campaign digital marketing materials has been developed and is available at www.england.nhs.uk/earlierbetter

If you would like further information about any aspect of the campaign, please email NHS England: england.marketing@nhs.net

Last updated on 20 March 2017.

Claims new blood test can detect Alzheimer's disease

ALZHEIMERS

“Blood test that can predict Alzheimer's,” was the headline used by BBC News, the Daily Mail and The Guardian today. Similar coverage was seen across many of the front pages of other newspapers.

These headlines reflected new research showing how a simple blood test may be able to detect early signs of cognitive decline and mild Alzheimer’s disease.

US researchers discovered a panel of 10 biomarkers that, with 90% accuracy, could distinguish people who would progress to have either mild cognitive impairment or mild Alzheimer’s disease within two to three years, from those who wouldn’t.

While promising, the results were only based on a small group of adults over 70 years old who were studied over five years. Of those who developed mild cognitive impairment or mild Alzheimer’s disease, only 28 people had the test. Consequently, it is not clear if the test has any predictive power, is applicable to younger adults, or can predict the disease more than two to three years in advance.

The Daily Mail outlined how, while the research was a breakthrough, experts had warned it would bring “ethical concerns”. This is an important point, because there is currently no cure for Alzheimer’s disease. The current unrefined test means at least one in 10 would be wrongly told they will go on to develop the condition, given the severity of the disease, this may cause significant needless worry.

Where did the story come from?

The study was carried out by researchers from a range of US Universities and Medical institutions and was funded by the US National Institutes of Health.

The study was published in the peer-reviewed medical journal, Nature Medicine.

The media reporting was generally balanced, with many highlighting the clear ethical question of whether there is any benefit in telling people they are likely to develop a serious condition that currently has no cure. Most media sources correctly acknowledged the need for more research to confirm the usefulness of the test, and that a useable test may be many years away.

However, while this research is exciting, it is still in an early stage and so front page coverage in four national newspapers is perhaps a little over-the-top.

What kind of research was this?

This was a cohort study looking to see if a blood test could detect Alzheimer’s disease before symptoms developed.

Alzheimer’s disease causes a progressive dementia. It affects more than 35 million individuals worldwide and is expected to affect 115 million by 2050.

There are currently no cures for the disease and no treatments to improve symptoms to any significant degree. This is because, at the moment, it is only possible to diagnose Alzheimer’s when symptoms such as memory loss show up. Unfortunately, this is usually long after the brain has deteriorated at a cellular level, meaning the disease is well underway by the time it is diagnosed.

Current tests for detecting early disease involve invasive medical treatments, which are also time consuming and often expensive. Discovering new tests and treatments targeting early stages of Alzheimer’s, before any outwardly obvious symptoms occur (known as pre-clinical disease), is a hot topic for research. Theoretically, detecting the disease early on will enable more options to be used to stop or slow down the progress of the disease.

Last updated on 20 March 2017.

Doubt over future of Reading mental health service

A mental health service in Berkshire could be under threat under cost-cutting proposals.

Reading Borough Council is reviewing its mental health recovery services in a bid to slash costs.

The authority will be looking at the care provided at Focus House, a CQC registered home for up to seven patients, as they recover.

Councillors are looking to change mental health services and "divert" Focus House users elsewhere.

The three-month consultation will start on Monday and comes as the authority faces a £44m funding gap "due to government cuts".

A spokesperson for the council said they would be looking to keep mental health services "cost effective and sustainable".

They added service users at Focus House could be sent to alternative accommodation to make savings.

Adult and social care councillor, Rachel Eden, said: "Unfortunately, due to major government funding cuts, the council cannot continue to support the existing service as it is."

Proposed changes to the Focus House service include diverting patients to different accommodation for support as they recover and facilities to help them improve their life skills.

If the proposal goes ahead the council said individual plans for patients and staff will be made.

 

Last updated on 20 March 2017.

Dementia now leading cause of death

Brain scan

Dementia, including Alzheimer's disease, has overtaken heart disease as the leading cause of death in England and Wales, latest figures reveal.

Last year, more than 61,000 people died of dementia - 11.6% of all recorded deaths.

The Office for National Statistics says the change is largely due to an ageing population.

People are living for longer and deaths from some other causes, including heart disease, have gone down.

Also, doctors have got better at diagnosing dementia and the condition is now given more weight on death certificates.

The bulk of the dementia deaths seen were among women - 41,283, compared to 20,403 dementia deaths in men in 2015.

Dementia, including Alzheimer's disease, accounted for 15.2% of all female deaths, up from 13.4% in 2014.

For men, however, heart disease remained the leading cause of death in 2015.

All types of cancer as a group was still the most common cause of death overall.

In the youngest age group, aged five to 19, suicide was the leading cause of death.

Among women aged 35 to 49, breast cancer was the biggest killer.

Hilary Evans of Alzheimer's Research UK said: "These figures once again call attention to the uncomfortable reality that currently, no-one survives a diagnosis of dementia.

"Dementia is not an inevitable part of ageing, it's caused by diseases that can be fought through research, and we must bring all our efforts to bear on what is now our greatest medical challenge."

Martina Kane of the Alzheimer's Society said: "It is essential that people have access to the right support and services to help them live well with dementia and that research into better care, treatments and eventually a cure remain high on the agenda."

There are around 850,000 people living with dementia in the UK.

Warning signs of dementia

Seek medical advice if your memory loss is affecting daily life and especially if you:

  • struggle to remember recent events, although you can easily recall things that happened in the past
  • find it hard to follow conversations or programmes on TV
  • forget the names of friends or everyday objects
  • cannot recall things you have heard, seen or read
  • lose the thread of what you are saying
  • have problems thinking and reasoning
  • feel anxious, depressed or angry
  • feel confused even when in a familiar environment or get lost on familiar journeys
  • find that other people start to notice or comment on your memory loss

Linda Trueman, 67 and from Hertfordshire, lost her mother, father and grandmother to dementia.

She says attitudes about the disease have changed, but some taboos remain.

"It was the 1970s when my grandmother died from dementia and really, at that time, most people didn't know the term Alzheimer's.

"And when my father died in 1987 there were several instances where I was explaining to the doctors about his Alzheimer's.

"Since then there's been a big change in knowledge and expertise. My mother died from dementia last Christmas and I was really impressed with the level of care she received. It was really touching and respectful the way she was treated.

"But it's still a condition that everyone is frightened of. People can find it difficult to be around those with dementia. I understand that. It can be really difficult to handle, particularly if they behave badly in public. But it's the disease, not the person."

Last updated on 17 November 2016.

Nearby Pharmacies

Find nearby Pharmacies

Electronic Prescription Service

This pharmacy offers the Electronic Prescription Service, which allows you to choose or “nominate” a pharmacy to get your medicines or appliances from. Your GP then sends your prescription electronically to the place you have nominated, this means:

  • If you collect your repeat prescriptions from your GP you will not have to visit your GP practice to pick up your paper prescription, saving you time.
  • You will have more choice about where to get your medicines from because they can be collected from a pharmacy near to where you live, work or shop.
  • You may not have to wait as long at the pharmacy as your repeat prescriptions could be prepared before you arrive.

Find out more

Last updated on 21 November 2019.

Information supplied by Thames Valley Area Team